{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T02:37:22Z","timestamp":1785033442944,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"the Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["21H02974"],"award-info":[{"award-number":["21H02974"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fund for the Promotion of Joint International Research","award":["19KK04071"],"award-info":[{"award-number":["19KK04071"]}]},{"DOI":"10.13039\/501100001691","name":"the Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["JP19H03708"],"award-info":[{"award-number":["JP19H03708"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-75645-1","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T06:04:40Z","timestamp":1730268280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparative analysis of aldosterone and renin assays for primary aldosteronism screening"],"prefix":"10.1038","volume":"14","author":[{"given":"Yuki","family":"Taki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Teruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Ichijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikki","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroka","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiryo","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"issue":"12","key":"75645_CR1","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","volume":"9","author":"M Reincke","year":"2021","unstructured":"Reincke, M. et al. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 9(12), 876\u2013892 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"75645_CR2","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","volume":"71","author":"Y Ohno","year":"2018","unstructured":"Ohno, Y. et al. Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: A multicenter study in Japan. Hypertension 71(3), 530\u2013537 (2018).","journal-title":"Hypertension"},{"issue":"7","key":"75645_CR3","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1038\/s41440-023-01288-w","volume":"46","author":"Y Yoshida","year":"2023","unstructured":"Yoshida, Y. & Shibata, H. Recent progress in the diagnosis and treatment of primary aldosteronism. Hypertens. Res. 46(7), 1738\u20131744 (2023).","journal-title":"Hypertens. Res."},{"issue":"3","key":"75645_CR4","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1210\/jc.2017-01530","volume":"103","author":"X Meng","year":"2018","unstructured":"Meng, X. et al. Evaluation of the saline infusion test and the captopril challenge test in Chinese patients with primary aldosteronism. J. Clin. Endocrinol. Metab. 103(3), 853\u2013860 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"75645_CR5","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1055\/s-0043-119755","volume":"49","author":"F Buffolo","year":"2017","unstructured":"Buffolo, F. et al. Is primary aldosteronism still largely unrecognized?. Horm. Metab. Res. 49(12), 908\u2013914 (2017).","journal-title":"Horm. Metab. Res."},{"issue":"9","key":"75645_CR6","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/ng.2695","volume":"45","author":"UI Scholl","year":"2013","unstructured":"Scholl, U. I. et al. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat. Genet. 45(9), 1050\u20131054 (2013).","journal-title":"Nat. Genet."},{"issue":"11","key":"75645_CR7","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi, G. P. et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J. Am. Coll. Cardiol. 48(11), 2293\u20132300 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"75645_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","volume":"69","author":"M Naruse","year":"2022","unstructured":"Naruse, M. et al. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr. J. 69(4), 327\u2013359 (2022).","journal-title":"Endocr. J."},{"issue":"4","key":"75645_CR9","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","volume":"75","author":"J Burrello","year":"2020","unstructured":"Burrello, J. et al. Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit. Hypertension 75(4), 1025\u20131033 (2020).","journal-title":"Hypertension"},{"issue":"3","key":"75645_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1055\/s-2007-970409","volume":"115","author":"F Mantero","year":"2007","unstructured":"Mantero, F., Mattarello, M. J. & Albiger, N. M. Detecting and treating primary aldosteronism: Primary aldosteronism. Exp. Clin. Endocrinol. Diabetes 115(3), 171\u2013174 (2007).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"5","key":"75645_CR11","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","volume":"69","author":"R Baudrand","year":"2017","unstructured":"Baudrand, R. et al. Continuum of renin-independent aldosteronism in normotension. Hypertension 69(5), 950\u2013956 (2017).","journal-title":"Hypertension"},{"issue":"4","key":"75645_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1507\/endocrj.KR-105","volume":"54","author":"T Nishikawa","year":"2007","unstructured":"Nishikawa, T., Saito, J. & Omura, M. Prevalence of primary aldosteronism: Should we screen for primary aldosteronism before treating hypertensive patients with medication?. Endocr. J. 54(4), 487\u2013495 (2007).","journal-title":"Endocr. J."},{"issue":"3","key":"75645_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1507\/endocrj.EJ20-0395","volume":"68","author":"S Chen","year":"2021","unstructured":"Chen, S., Liu, H., Luo, P. & Yu, Y. Computed tomography combined with confirmatory tests for the diagnosis of aldosterone-producing adenoma. Endocr. J. 68(3), 299\u2013306 (2021).","journal-title":"Endocr. J."},{"issue":"1","key":"75645_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/ejendo\/lvac002","volume":"188","author":"M Naruse","year":"2023","unstructured":"Naruse, M. et al. International multicenter survey on screening and confirmatory testing in primary aldosteronism. Eur. J. Endocrinol. 188(1), 125\u2013134 (2023).","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"75645_CR15","doi-asserted-by":"publisher","first-page":"e0253807","DOI":"10.1371\/journal.pone.0253807","volume":"16","author":"N Tamura","year":"2021","unstructured":"Tamura, N. et al. Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism. PLoS One 16(7), e0253807 (2021).","journal-title":"PLoS One"},{"issue":"1","key":"75645_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1210\/jcem-34-1-106","volume":"34","author":"T Ito","year":"1972","unstructured":"Ito, T., Woo, J., Haning, R. & Horton, R. A radioimmunoassay for aldosterone in human peripheral plasma including a comparison of alternate techniques. J. Clin. Endocrinol. Metab. 34(1), 106\u2013112 (1972).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"75645_CR17","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura, S. et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens. Res. 42(9), 1235\u20131481 (2019).","journal-title":"Hypertens. Res."},{"issue":"12","key":"75645_CR18","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/jhh.2017.62","volume":"31","author":"F Pizzolo","year":"2017","unstructured":"Pizzolo, F. et al. Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up. J. Hum. Hypertens. 31(12), 826\u2013830 (2017).","journal-title":"J. Hum. Hypertens."},{"issue":"12","key":"75645_CR19","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1507\/endocrj.EJ16-0304","volume":"63","author":"T Nishikawa","year":"2016","unstructured":"Nishikawa, T. et al. Calibration and evaluation of routine methods by serum certified reference material for aldosterone measurement in blood. Endocr. J. 63(12), 1065\u20131080 (2016).","journal-title":"Endocr. J."},{"issue":"5","key":"75645_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1507\/endocrj.EJ22-0585","volume":"70","author":"H Kobayashi","year":"2023","unstructured":"Kobayashi, H. et al. Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism. Endocr. J. 70(5), 489\u2013500 (2023).","journal-title":"Endocr. J."},{"issue":"1","key":"75645_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41371-020-00465-5","volume":"36","author":"K Teruyama","year":"2021","unstructured":"Teruyama, K., Naruse, M., Tsuiki, M. & Kobayashi, H. Novel chemiluminescent immunoassay to measure plasma aldosterone and plasma active renin concentrations for the diagnosis of primary aldosteronism. J. Hum. Hypertens. 36(1), 77\u201385 (2021).","journal-title":"J. Hum. Hypertens."},{"issue":"1","key":"75645_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1507\/endocrj.EJ21-0278","volume":"69","author":"T Nishikawa","year":"2022","unstructured":"Nishikawa, T. et al. Comparison and commutability study between standardized liquid chromatography-mass spectrometry\/mass spectrometry (LC-MS\/MS) and chemiluminescent enzyme immunoassay for aldosterone measurement in blood. Endocr. J. 69(1), 45\u201354 (2022).","journal-title":"Endocr. J."},{"key":"75645_CR23","doi-asserted-by":"publisher","first-page":"100453","DOI":"10.1016\/j.jlr.2023.100453","volume":"6","author":"J Noh","year":"2023","unstructured":"Noh, J., Lee, C., Kim, J. H., Myung, S. W. & Choi, M. H. LC-MS based simultaneous profiling of adrenal hormones of steroids, catecholamines, and metanephrines. J. Lipid Res. 6, 100453 (2023).","journal-title":"J. Lipid Res."},{"issue":"1","key":"75645_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1210\/clinem\/dgac568","volume":"108","author":"E Ng","year":"2022","unstructured":"Ng, E. et al. Aldosterone, renin, and aldosterone-to-renin ratio variability in screening for primary aldosteronism. J. Clin. Endocrinol. Metab. 108(1), 33\u201341 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"75645_CR25","doi-asserted-by":"publisher","first-page":"122740","DOI":"10.1016\/j.jchromb.2021.122740","volume":"1179","author":"F Chen","year":"2021","unstructured":"Chen, F. et al. A liquid chromatography-tandem mass spectrometry (LC-MS\/MS)-based assay for simultaneous quantification of aldosterone, renin activity, and angiotensin II in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1179, 122740 (2021).","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"11","key":"75645_CR26","doi-asserted-by":"publisher","first-page":"e24738","DOI":"10.1002\/jcla.24738","volume":"36","author":"Z Liu","year":"2022","unstructured":"Liu, Z., Jin, L., Zhou, W. & Zhang, C. The spectrum of plasma renin activity and hypertension diseases: Utility, outlook, and suggestions. J. Clin. Lab. Anal. 36(11), e24738 (2022).","journal-title":"J. Clin. Lab. Anal."},{"key":"75645_CR27","doi-asserted-by":"publisher","first-page":"460456","DOI":"10.1016\/j.chroma.2019.460456","volume":"1609","author":"X Tan","year":"2020","unstructured":"Tan, X., Li, F., Wang, X. & Wang, Y. Quantitation and clinical evaluation of plasma aldosterone by ultra-performance liquid chromatography\u2013mass spectrometry. J. Chromatogr. A 1609, 460456 (2020).","journal-title":"J. Chromatogr. A"},{"key":"75645_CR28","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1097\/01.hjh.0000939192.01041.c0","volume":"41","author":"F Satoh","year":"2023","unstructured":"Satoh, F. et al. New screening cutoff values for detection of aldosteronoma examined by LC-MS\/MS and newly developed non-competitive Cleia. J. Hypertens. 41, e36 (2023).","journal-title":"J. Hypertens."},{"issue":"6","key":"75645_CR29","doi-asserted-by":"publisher","first-page":"bvae080","DOI":"10.1210\/jendso\/bvae080","volume":"8","author":"Y Ono","year":"2024","unstructured":"Ono, Y. et al. Screening cutoff values for the detection of aldosterone-producing adenoma by LC-MS\/MS and a novel noncompetitive CLEIA. J. Endocr. Soc. 8(6), bvae080 (2024).","journal-title":"J. Endocr. Soc."},{"issue":"7","key":"75645_CR30","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1097\/HJH.0000000000001718","volume":"36","author":"WMCM Vorselaars","year":"2018","unstructured":"Vorselaars, W. M. C. M., Valk, G. D., Vriens, M. R., Westerink, J. & Spiering, W. Case detection in primary aldosteronism: High-diagnostic value of the aldosterone-to-renin ratio when performed under standardized conditions. J. Hypertens. 36(7), 1585\u20131591 (2018).","journal-title":"J. Hypertens."},{"issue":"6","key":"75645_CR31","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.amjhyper.2005.01.002","volume":"18","author":"MK Nishizaka","year":"2005","unstructured":"Nishizaka, M. K., Pratt-Ubunama, M., Zaman, M. A., Cofield, S. & Calhoun, D. A. Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension\u201d. Am. J. Hypertens. 18(6), 805\u2013812 (2005).","journal-title":"Am. J. Hypertens."},{"issue":"6","key":"75645_CR32","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","volume":"40","author":"DA Calhoun","year":"2002","unstructured":"Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B. & Weissmann, P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40(6), 892\u2013896 (2002).","journal-title":"Hypertension"},{"issue":"6","key":"75645_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1055\/a-1139-2079","volume":"52","author":"CE Gomez-Sanchez","year":"2020","unstructured":"Gomez-Sanchez, C. E. et al. Immunohistochemistry of the human adrenal CYP11B2 in normal individuals and in patients with primary aldosteronism. Horm. Metab. Res. 52(6), 421\u2013426 (2020).","journal-title":"Horm. Metab. Res."},{"issue":"18","key":"75645_CR34","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.clinbiochem.2017.08.015","volume":"50","author":"G Ward","year":"2017","unstructured":"Ward, G., Simpson, A., Boscato, L. & Hickman, P. E. The investigation of interferences in immunoassay. Clin. Biochem. 50(18), 1306\u20131311 (2017).","journal-title":"Clin. Biochem."},{"issue":"3","key":"75645_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1530\/eje.0.1500329","volume":"150","author":"L Seiler","year":"2004","unstructured":"Seiler, L. et al. Diagnosis of primary aldosteronism: Value of different screening parameters and influence of antihypertensive medication. Eur. J. Endocrinol. 150(3), 329\u2013337 (2004).","journal-title":"Eur. J. Endocrinol."},{"issue":"5\u20136","key":"75645_CR36","first-page":"701","volume":"28","author":"HU Tuhan","year":"2015","unstructured":"Tuhan, H. U. et al. Cross-reactivity of adrenal steroids with aldosterone may prevent the accurate diagnosis of congenital adrenal hyperplasia. J. Pediatr. Endocrinol. Metab. 28(5\u20136), 701\u2013704 (2015).","journal-title":"J. Pediatr. Endocrinol. Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75645-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75645-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75645-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T23:03:19Z","timestamp":1730502199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75645-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["75645"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-75645-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]},"assertion":[{"value":"4 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors affiliated with Chiba University and Saiseikai Yokohamashi Tobu Hospital (Yuki Taki, Takashi Kono, Hidekazu Nagano, Hiroka Miyagawa, Satomi Kono, Masanori Fujimoto, Ikki Sakuma, Naoko Hashimoto, Masataka Yokoyama, Eiryo Kawakami, Takashi Miki, Tomoaki Tanaka, and Takamasa Ichijo, respectively) have no competing financial interests. Kyoko Teruyama is a full-time employee of Fujirebio Inc. and has no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26040"}}